Revium Rx (RVRC) Payables (2024 - 2026)

Revium Rx has disclosed Payables across 3 years of filings, most recently posting $621000.0 for Q2 2026.

• In Q2 2026, Payables changed N/A year-over-year to $621000.0; the TTM figure through Jun 2026 stood at $621000.0 (changed N/A YoY), while the FY2025 annual figure was $164000.0, down 54.32% from the prior year.
• Payables came in at $621000.0 for Q2 2026 at Revium Rx, up from $164000.0 in the prior quarter.
• In the past five years, Payables ranged from a high of $621000.0 in Q2 2026 to a low of $164000.0 in Q4 2025.
• Average Payables over 3 years is $381333.3, with a median of $359000.0 recorded in 2024.
• The largest YoY upside for Payables was 54.32% in 2025 against a maximum downside of 54.32% in 2025.
• Over 3 years, Payables stood at $359000.0 in 2024, then tumbled by 54.32% to $164000.0 in 2025, then surged by 278.66% to $621000.0 in 2026.
• Per Business Quant data, the three most recent Payables figures were $621000.0 in Q2 2026, $164000.0 in Q4 2025, and $359000.0 in Q4 2024.